Kiven Erique Lukong

Trends in Genetics · 2008–2014

A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Kiven Erique Lukong trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Suzanne Schubbert
  2. K. Shannon

Papers from Kiven Erique Lukong's perspective

Ordered by how strongly the researchers Kiven Erique Lukong trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Oncogenic kinase signalling (Nature)
  2. Transcriptional Regulation of the Human Tumor Suppressor DOK1 by E2F1
  3. Modification of proteins by ubiquitin and ubiquitin-like proteins. (Annual Review of Cell and Developmental Biology)
  4. Cancer epigenetics reaches mainstream oncology (Nature Medicine)
  5. Dok1 encoding p62(dok) maps to mouse chromosome 6 and human chromosome 2 in a region of translocation in chronic lymphocytic leukemia.
  6. Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia (Nature Reviews. Cancer)
  7. Hyperactive Ras in developmental disorders and cancer (Nature Reviews. Cancer)
  8. Targeting RAS signalling pathways in cancer therapy (Nature Reviews. Cancer)
  9. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome (Nature Genetics)
  10. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. (Genes & Development)

Their papers